Dec 12, 2016 · Patients who passed the 5-year landmark event-free survival (N=394) had a 79% probability (95% CI, 73-85) of surviving the subsequent 5 years ...
Dec 12, 2016 · Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow ...
Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation. M van ...
Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation.
Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation. https ...
People also ask
How long can a leukemia patient live after a bone marrow transplant?
What is the survival rate for all leukemia patients after stem cell transplant?
Does bone marrow transplant work for CLL?
What is the success rate of allogeneic bone marrow transplant?
Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation. Bone ...
Disease status is another key determinant of outcomes after allogeneic HCT, with multiple studies consistently reporting lower relapse rates and improved PFS ...
These long-term results indicate that RIC allo-SCT provides long-term disease control in ∼40% of patients and that allo-SCT is able to overcome the negative ...
May 20, 2020 · In CLL, allo-HCT can induce long-term disease control and overcome the poor prognostic impact of del(17p) and fludarabine refractoriness.
Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation · Overview ...